Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)

This grant opportunity, PAR-26-107 (CFDA: 93.310), focuses on discovering the genetic basis of childhood cancers and congenital anomalies through the Gabriella Miller Kids First Pediatric Research Program. Clinical trials are not allowed under this funding opportunity.